A. We avoid using the term lifelong and usually postpones giving such information until asked or confronted. This is because, at the outset of managing a patient, it is unclear whether or not remission of psychosis is likely to be long-lasting or if the patient is at high risk of persistent symptoms. The first visit is too early to make such a judgement, especially if there are problems with compliance.
A. Initially, the necessity for therapy is emphasised. Such therapy lasts 1 year or longer, depending on the course of the disease.
A. The presence of psychotic symptoms impacts on a patient’s quality of life as do participating in social activities and being in paid employment.
A. We take a holistic approach to patient management. We not only prescribe the most suitable therapy but we work with psychologists to get to know and understand our patients.
A. Neither. Schizophrenia is a heterogeneous disease and looking at it from either perspective doesn’t help us as psychiatrists to choose the most appropriate therapies. More needs to be known about the role that a history of trauma or genetics plays and we really don’t know how neurodevelopmental disorders are brought about.
A. About 30% of patients can improve their relationships.